Is Pfizer Inc. (PFE) a Buy, Sell, or Hold?
NYSE : PFE
Pfizer Inc. — Institutional Ownership
$24.54 USD
-$0.47 (-1.88%)
- Volume
- 22.86M
- Average Volume
- 41.23M
- Market Capitalization
- $139.86B
- P/E Ratio
- 18.73
- Dividend Yield
- 7.01%
- Price Target
- $27.00
- Year High
- $28.75
- Year Low
- $23.11
- Day High
- —
- Day Low
- —
- Payout Ratio
- $1.31
- Current Ratio
- $1.25
Institutional Ownership Summary
Institutional Ownership %
2.52%
Investors Holding
906
change: -2153 | last: 3059
Increased Positions
398
change: -1156 | last: 1554
Reduced Positions
402
change: -687 | last: 1089
New Positions
34
change: -216 | last: 250
Sold Positions
2083
change: 1851 | last: 232
Total Calls
3800
Total Puts
139.5K
Put-Call Ratio
36.71
change: 3584.8906 | last: 0.8616
Total Invested
3.58B
Beneficial Ownership Filings
| Filing Date | Reporting Person | Amount Beneficially Owned | % of Class |
|---|---|---|---|
| 2026-03-27 | The Vanguard Group | - | 0.00% |
| 2026-02-13 | Pfizer Inc. | 22.03M | 9.00% |
| 2025-03-24 | Pfizer Inc. | - | 0.00% |
| 2025-03-20 | Pfizer Inc. | 661.71M | 7.30% |
| 2025-02-27 | Pfizer Inc. | 661.71M | 7.30% |
| 2025-02-12 | Pfizer Inc. 13-5315170 | 2.97M | 4.60% |
| 2025-02-12 | Pfizer Inc. 13-5315170 | 2.41M | 3.60% |
| 2025-01-21 | Pfizer Inc. | 661.71M | 7.30% |
| 2025-01-16 | Pfizer Inc. | 1.36B | 15.00% |
| 2023-10-27 | PFIZER INC. | 1.27M | 6.26% |
| 2023-10-10 | ”) | 2.96B | 32.00% |
| 2023-07-10 | PFIZER INC. | 4.69M | 7.10% |
| 2023-03-30 | Pfizer Inc. | 2.97M | 10.78% |
| 2023-02-13 | Anacor Pharmaceuticals, LLC 25-1854385 | 1.36M | 7.02% |
| 2023-02-13 | Pfizer Inc. 13-5315170 | 1.36M | 7.02% |
| 2022-12-29 | PFIZER INC. | 5.38M | 12.00% |
| 2022-07-27 | ”) | 2.96B | 32.00% |
| 2022-06-29 | PFIZER INC. 13-5315170 | 9.55M | 8.10% |
| 2022-06-28 | PFIZER INC. 13-5315170 | 2.53M | 6.70% |
| 2022-03-21 | Pfizer Inc. (“Pfizer”) | 3.98M | 23.10% |
| 2022-03-21 | Arena Pharmaceuticals, Inc. | 3.98M | 23.10% |
| 2022-02-14 | ( 81-4343957 | 1.88M | 4.65% |
| 2022-02-14 | STATE STREET CORPORATION | 285.77M | 5.09% |
| 2022-02-14 | ( 82-5524518 | 365.04K | 0.90% |
| 2022-02-14 | ( 13-5315170 | 2.24M | 5.56% |
| 2022-02-11 | Pfizer Inc. 13-5315170 | 2.99M | 9.13% |
| 2022-02-14 | (VOLUNTARY) 98-1625216 | 600K | 2.01% |
| 2022-02-14 | Pfizer Inc. 13-5315170 | 600K | 2.01% |
| 2022-02-11 | Pfizer Inc. 13-5315170 | 1.88M | 3.19% |
| 2022-02-11 | Pfizer Inc. 13-5315170 | 1.37M | 3.88% |
| 2022-02-14 | (VOLUNTARY) 98-1625134 | 2.33M | 4.73% |
| 2022-02-11 | Pfizer Inc. 13-5315170 | 341.66K | 1.06% |
| 2022-02-11 | Pfizer Inc. 13-5315170 | 1.68M | 3.81% |
| 2022-02-14 | ( 13-5315170 | 1.79M | 4.54% |
| 2022-02-11 | Pfizer Ventures (US) LLC 82-5524518 | 341.66K | 1.06% |
| 2022-02-11 | Pfizer Ventures (US) LLC 82-5524518 | 2.99M | 9.13% |
| 2022-02-14 | Pfizer Inc. 13-5315170 | 2.34M | 4.75% |
| 2022-02-11 | Pfizer Ventures (US) LLC 82-5524518 | 1.37M | 3.88% |
| 2022-02-11 | Pfizer Ventures (US) LLC 82-5524518 | 1.88M | 3.19% |
| 2022-02-10 | The Vanguard Group - 23-1945930 | 465.27M | 8.29% |
| 2022-02-01 | (1) BlackRock, Inc. | 409.99M | 7.30% |
| 2021-11-19 | PFIZER INC. | 2.41M | 5.75% |
| 2021-09-20 | PFIZER INC. | 3.46M | 6.60% |
| 2021-07-09 | PFIZER INC. | 2.36M | 7.37% |
| 2021-03-25 | ( 81-4334429 | 215.7K | 0.70% |
| 2021-03-25 | ( 13-5315170 | 2.06M | 7.00% |
| 2021-03-25 | ( 82-5524518 | 1.59M | 5.40% |
| 2021-02-16 | ( 81-4334429 | 215.7K | 0.70% |
| 2021-02-16 | Pfizer Inc. | 1.67M | 6.30% |
| 2021-02-12 | Pfizer Ventures (US) LLC | 576.6K | 1.20% |
| 2021-02-12 | Pfizer Ventures (US) LLC | 1.21M | 3.90% |
| 2021-02-16 | Pfizer Ventures (US) LLC | 1.32M | 5.00% |
| 2021-02-16 | Pfizer Ventures (US) LLC | 2.24M | 7.00% |
| 2021-02-16 | Pfizer Inc. | 2.24M | 7.00% |
| 2021-02-16 | ( 82-5524518 | 1.67M | 5.70% |
| 2021-02-16 | ( 13-5315170 | 2.14M | 7.30% |
| 2021-02-12 | ( 13-5315170 | - | 0.00% |
| 2021-02-12 | STATE STREET CORPORATION | 279.83M | 5.03% |
| 2021-02-12 | ( 13-5315170 | 1.79M | 6.40% |
| 2021-02-12 | Pfizer Inc. | 4.58M | 9.40% |
| 2021-02-12 | Pfizer Inc. | 1.27M | 4.10% |
| 2021-02-10 | The Vanguard Group - 23-1945930 | 447.96M | 8.06% |
| 2021-01-29 | (1) BlackRock, Inc. | 396.97M | 7.10% |
| 2020-11-19 | Pfizer Inc. | 5M | 9.90% |
| 2020-11-06 | ”) | 27.35M | 21.50% |
| 2020-08-06 | Pfizer Inc. | 1.68M | 6.00% |
| 2020-03-26 | Pfizer Ventures (US) LLC | 1.48M | 8.90% |
| 2020-03-26 | Pfizer Inc. | 1.56M | 9.40% |
| 2020-02-14 | Pfizer Inc. | 4.59M | 10.70% |
| 2020-02-14 | Pfizer Ventures (US) LLC | 1.47M | 3.47% |
| 2020-02-14 | Pfizer Inc. | 2.53M | 8.30% |
| 2020-02-14 | Pfizer Ventures (US) LLC | 576.6K | 1.30% |
| 2020-02-13 | STATE STREET CORPORATION | 292.63M | 5.28% |
| 2020-02-12 | The Vanguard Group - 23-1945930 | 449.96M | 8.13% |
| 2020-02-05 | (1) BlackRock, Inc. | 426.23M | 7.70% |
| 2019-12-16 | ( 13-5315170 | 11.11M | 8.70% |
| 2019-05-22 | ( 82-5524518 | 1.64M | 7.20% |
| 2019-05-22 | ( 13-5315170 | 3.25M | 12.20% |
| 2019-05-22 | ( 81-4334429 | 215.7K | 0.80% |
| 2019-05-22 | ( 82-5524518 | 2.41M | 9.00% |
| 2019-02-14 | STATE STREET CORPORATION | 296.23M | 5.10% |
| 2019-02-06 | (1) BlackRock, Inc. | 462.85M | 8.00% |
| 2018-10-22 | ”) | 22.03M | 18.70% |
| 2018-02-14 | STATE STREET CORPORATION | 312.94M | 5.25% |
| 2018-02-13 | ( 13-5315170 | 356.8K | 1.67% |
| 2018-02-13 | ( 13-5315170 | 260.94K | 1.34% |
| 2018-02-13 | ( 13-5315170 | - | 0.00% |
| 2018-02-13 | ( 13-5315170 | 2.21M | 9.71% |
| 2018-02-08 | (1) BlackRock, Inc. | 452.79M | 7.60% |
| 2017-10-18 | Pfizer Inc. | 1.43M | 5.40% |
| 2017-07-13 | PFIZER INC. | 2.23M | 9.80% |
| 2017-02-08 | STATE STREET CORPORATION | 322.4M | 5.31% |
| 2016-06-06 | ( 13-5315170 | 1.14M | 11.00% |
| 2016-05-12 | ( 52-2090275 | 1.88M | 11.00% |
| 2016-05-12 | ( 98-0182045 | 1.88M | 11.00% |
| 2016-05-12 | ( 13-5315170 | 1.88M | 11.00% |
| 2016-05-12 | 52-2090292 | 1.88M | 11.00% |
| 2016-04-04 | ( 13-5315170 | 121.9K | 11.00% |
| 2016-02-16 | STATE STREET CORPORATION | 313.88M | 5.10% |
| 2016-02-11 | ( 13-5606163 | - | 11.00% |
| 2016-02-11 | ( 13-5315170 | 1.83M | 11.00% |
| 2016-02-10 | (1) BlackRock, Inc. | 407.53M | 6.60% |
| 2015-10-23 | ( 98-0182045 | 5.65M | 11.00% |
| 2015-10-23 | 52-2090292 | 5.65M | 11.00% |
| 2015-10-23 | ( 13-5315170 | 5.65M | 11.00% |
| 2015-10-23 | ( 52-2090275 | 5.65M | 11.00% |
| 2015-10-21 | ( 13-5315170 | 2.02M | 11.00% |
| 2015-10-14 | ( 13-5315170 | 2.49M | 11.00% |
| 2015-08-18 | ( 13-5315170 | 481.53K | 11.00% |
| 2015-02-09 | (1) BlackRock, Inc. | 445.83M | 7.10% |
| 2015-02-05 | ( 13-5315170 | 966.22K | 11.00% |
| 2014-03-21 | ( 13-5315170 | 1.24M | 11.00% |
| 2014-02-14 | ( 13-5315170 | 1.79M | 11.00% |
| 2014-02-10 | (1) BlackRock, Inc. | 421.86M | 6.50% |
| 2013-09-27 | ( 13-5606163 | 1.54M | 11.00% |
| 2013-02-05 | (1) BlackRock, Inc. | 467.53M | 6.35% |
| 2012-03-09 | 189464100 | 1.18M | 11.00% |
| 2012-02-13 | (1) BlackRock, Inc. | 463.84M | 6.03% |
| 2011-02-08 | (1) BlackRock, Inc. | 401.34M | 5.01% |
| 2010-01-29 | BlackRock for purposes of Schedule 13G filings. | 468.16M | 5.80% |
| 2008-02-22 | ( 13-5315170 | 8.54M | 11.00% |
| 2008-01-04 | 13-5315170 | 24.42M | 91.30% |
| 2008-01-04 | 26-1590228 | 24.42M | 91.30% |
| 2008-01-04 | 26-1318938 | 24.42M | 91.30% |
| 2007-08-28 | ( 13-5315170 | 2.69M | 11.00% |
| 2007-06-22 | ( 13-5315170 | 1.55M | 11.00% |
| 2007-01-23 | BARCLAYS GLOBAL INVESTORS JAPAN LIMITED | 6.8M | 0.09% |
| 2007-01-23 | BARCLAYS GLOBAL FUND ADVISORS | 46.01M | 0.64% |
| 2007-01-23 | BARCLAYS GLOBAL INVESTORS JAPAN TRUST AND BANKING COMPANY LIMITED | 7.65M | 0.11% |
| 2007-01-23 | BARCLAYS GLOBAL INVESTORS, LTD | 38.36M | 0.53% |
| 2007-01-23 | 943112180 | 278.73M | 3.87% |
| 2004-02-12 | Pfizer Health AB (formerly called Pharmacia & Upjohn AB) | 4M | 41.00% |
| 2004-02-12 | 1. | 4M | 41.00% |
| 1998-05-28 | 13-5315170 | 864.55K | 6.40% |
| 1997-02-13 | 13-5315170 | 1.25M | 4.40% |
| 1997-02-13 | 13-5315170 | 900K | 4.40% |
| 1997-02-13 | 13-5315170 | 99271.0 | 0.90% |
PFE Enterprise Value History
Annual
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2025-12-31 | $24.90 | 5.68B | $141.5B | $1.14B | $67.42B | $207.77B |
| 2024-12-31 | $26.53 | 5.66B | $150.27B | $1.04B | $66.99B | $216.22B |
| 2023-12-31 | $28.79 | 5.64B | $162.46B | $2.85B | $70.84B | $230.45B |
| 2022-12-31 | $51.24 | 5.61B | $287.35B | $416M | $34.86B | $321.8B |
| 2021-12-31 | $59.05 | 5.6B | $330.74B | $1.94B | $37B | $365.79B |
| 2020-12-31 | $36.81 | 5.56B | $204.48B | $1.79B | $38.27B | $240.97B |
| 2019-12-31 | $37.14 | 5.57B | $206.83B | $1.12B | $50.84B | $256.55B |
| 2018-12-31 | $41.38 | 5.87B | $242.98B | $1.14B | $41.74B | $283.59B |
| 2017-12-31 | $34.33 | 5.97B | $204.95B | $1.34B | $42.61B | $246.21B |
| 2016-12-31 | $30.79 | 6.09B | $187.48B | $2.6B | $41.06B | $225.95B |
Quarterly
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2026-03-29 | $27.77 | 5.69B | $158.04B | $1.7B | $64.46B | $220.79B |
| 2025-12-31 | $24.90 | 5.68B | $141.5B | $1.14B | $67.42B | $207.77B |
| 2025-09-28 | $23.85 | 5.68B | $135.59B | $1.34B | $61.71B | $195.96B |
| 2025-06-29 | $24.24 | 5.68B | $137.8B | $1.64B | $61.8B | $197.96B |
| 2025-03-29 | $25.34 | 5.68B | $143.8B | $1.43B | $61.29B | $203.67B |
| 2024-12-31 | $26.53 | 5.67B | $150.35B | $1.04B | $63.65B | $212.95B |
| 2024-09-29 | $28.94 | 5.67B | $164B | $1.09B | $66.62B | $229.53B |
| 2024-06-30 | $28.22 | 5.67B | $159.89B | $1.05B | $68.68B | $227.52B |
| 2024-03-31 | $27.72 | 5.66B | $156.81B | $719M | $68.71B | $224.8B |
| 2023-12-31 | $28.79 | 5.65B | $162.58B | $2.85B | $70.84B | $230.57B |
| 2023-10-01 | $33.94 | 5.65B | $191.63B | $3.15B | $63.6B | $252.07B |
| 2023-07-02 | $36.65 | 5.65B | $206.93B | $2.63B | $65.34B | $269.63B |